BioVie Inc (NASDAQ: BIVI) open the trading on Thursday, with great promise as it jumped 6.24% to $0.50, before settling in for the price of $0.47 at the close. Taking a more long-term approach, BIVI posted a 52-week range of $0.44-$8.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. Meanwhile, its Annual Earning per share during the time was 16.23%. This publicly-traded company’s shares outstanding now amounts to $36.43 million, simultaneously with a float of $33.20 million. The organization now has a market capitalization sitting at $27.20 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8681, while the 200-day Moving Average is $2.5998.
BioVie Inc (BIVI) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. BioVie Inc’s current insider ownership accounts for 39.55%, in contrast to 3.90% institutional ownership. According to the most recent insider trade that took place on Dec 01 ’23, this organization’s Director sold 75,680 shares at the rate of 1.69, making the entire transaction reach 127,899 in total value, affecting insider ownership by 46,358. Preceding that transaction, on Nov 30 ’23, Company’s President & CEO bought 10,000 for 1.78, making the whole transaction’s value amount to 17,800. This particular insider is now the holder of 68,759 in total.
BioVie Inc (BIVI) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 12/30/2023 suggests? It has posted -$0.22 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.32) by $0.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
BioVie Inc (NASDAQ: BIVI) Trading Performance Indicators
Let’s observe the current performance indicators for BioVie Inc (BIVI). It’s Quick Ratio in the last reported quarter now stands at 1.47. The Stock has managed to achieve an average true range (ATR) of 0.08.
In the same vein, BIVI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.19.
Technical Analysis of BioVie Inc (BIVI)
[BioVie Inc, BIVI] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 26.32% While, its Average True Range was 0.0553.
Raw Stochastic average of BioVie Inc (BIVI) in the period of the previous 100 days is set at 0.94%, which indicates a major fall in contrast to 32.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 58.07% that was lower than 207.07% volatility it exhibited in the past 100-days period.
